Бангладеш - английски - DGDA (Directorate General of Drug Administration)

orion pharma ltd. - aluminium hydroxide + magnesium hydroxide - tablet - 250 mg + 400 mg

Бангладеш - английски - DGDA (Directorate General of Drug Administration)

orion pharma ltd. - aluminium oxide + magnesium hydroxide - suspension - 175 mg + 225 mg/5 ml

Бангладеш - английски - DGDA (Directorate General of Drug Administration)

orion pharma ltd. - aluminium hydroxide + magnesium hydroxide - tablet - 250 mg + 400 mg

Бангладеш - английски - DGDA (Directorate General of Drug Administration)

orion pharma ltd. - aluminium oxide + magnesium hydroxide - suspension - 175 mg + 225 mg/5 ml

Австралия - английски - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - water for injections, quantity: 3 ml - injection, diluent for - excipient ingredients: - berinert iv is indicated for the treatment of acute attacks in patients with hereditary angioedema (hae).

Австралия - английски - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - deoxycholic acid, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; water for injections; dibasic sodium phosphate heptahydrate; hydrochloric acid - belkyra (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults

Австралия - английски - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - water for injections, quantity: 40 ml - injection, solution - excipient ingredients: - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - water for injections, quantity: 4.2 ml - injection - excipient ingredients: - firmagon is a gnrh receptor blocker indicated for treatment of patients with prostate cancer in whom androgen deprivation is warranted.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - water for injections, quantity: 3 ml - injection - excipient ingredients: - firmagon is a gnrh receptor blocker indicated for treatment of patients with prostate cancer in whom androgen deprivation is warranted.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - water for injections, quantity: 10 ml - injection, diluent for - excipient ingredients: - berinert iv is indicated for the treatment of acute attacks in patients with hereditary angioedema (hae).